Evaluating small-molecule nicotinamide N-methyltransferase (NNMT) inhibitors requires absolute confidence in compound identity, chemical purity, and batch-to-batch consistency. High-Performance Liquid Chromatography (HPLC) combined with mass spectrometry serves as the gold standard for verifying 5-amino-1mq purity prior to preclinical and in vitro assays. This technical reference provides researchers with complete analytical specifications, COA interpretation guidelines, and laboratory handling protocols for 5-Amino-1MQ.
Evaluating small-molecule nicotinamide N-methyltransferase (NNMT) inhibitors requires absolute confidence in compound identity, chemical purity, and batch-to-batch consistency. High-Performance Liquid Chromatography (HPLC) combined with mass spectrometry serves as the gold standard for verifying 5-amino-1mq purity prior to preclinical and in vitro assays. This technical reference provides researchers with complete analytical specifications, COA interpretation guidelines, and laboratory handling protocols for 5-Amino-1MQ.
Evaluating 5-amino-1mq hplc data utilizes reverse-phase high-performance liquid chromatography paired with electrospray ionization mass spectrometry (ESI-MS) to verify chemical identity and quantitative 5-amino-1mq purity exceeding 98.0%. As a selective small-molecule inhibitor of Nicotinamide N-Methyltransferase (NNMT), laboratory-grade 5-Amino-1MQ requires rigorous analytical testing to ensure freedom from synthesis byproducts, toxic residual solvents, and bacterial endotoxins prior to in vitro cell culture or animal research models.
Analytical verification of 5-Amino-1MQ relies on robust chromatographic separation parameters designed to resolve the primary quinoline derivative from minor synthesis intermediates. High resolution on a C18 stationary phase allows research teams to accurately quantify both main peak area integration and baseline impurity profiles, ensuring reproducible baseline data across long-term experimental series.
Nicotinamide N-Methyltransferase (NNMT) is a cytosolic enzyme that catalyzes the transfer of a methyl group from S-adenosylmethionine (SAM) to nicotinamide (NAM), producing 1-methylnicotinamide (MNA) and S-adenosylhomocysteine (SAH). In adipose tissue and liver parenchymal cells, overexpression of NNMT alters cellular energy homeostasis by draining the available pool of nicotinamide, thereby dampening the salvage pathway responsible for synthesizing nicotinamide adenine dinucleotide (NAD+).
Preclinical studies suggest that targeted inhibition of NNMT using 5-Amino-1MQ effectively rescues intracellular NAD+ availability. By preserving NAD+, cells maintain higher flux through NAD+-dependent pathways, supporting enhanced mitochondrial respiration, increased SIRT1 enzyme activation, and upregulated fatty acid oxidation. Consequently, researchers routinely deploy verified research peptides and targeted small molecules within our research library to investigate metabolic flux, obesity models, and age-related mitochondrial dysfunction in cellular and animal frameworks.
To achieve accurate 5-amino-1mq hplc quantification, analytical laboratories utilize Reverse-Phase HPLC (RP-HPLC) equipped with a hydrophobic stationary phase, such as a C18 silica column (4.6 mm x 150 mm, 3.5 µm particle size). Because 5-Amino-1MQ (1-methyl-5-aminoquinolinium derivative) possesses polar ionic characteristics, precise mobile phase modifier selection is critical to prevent peak tailing and ensure sharp retention profiles.
A typical chromatographic method employs a linear gradient elution system comprising Mobile Phase A (0.1% trifluoroacetic acid in LC-MS grade water) and Mobile Phase B (0.1% trifluoroacetic acid in LC-MS grade acetonitrile). The UV detection system is optimized at 254 nm and 280 nm, matching the conjugated aromatic absorption profile of the quinoline core. Chromatographic software integrates peak areas to calculate absolute 5-amino-1mq purity, ensuring that secondary peaks—representing residual starting reagents or degradation products—remain strictly under specified thresholds.
While RP-HPLC provides precise quantitative separation of chemical species, mass spectrometry is necessary to confirm the structural identity of the analyte. Electrospray Ionization Mass Spectrometry (ESI-MS) operated in positive ion mode provides unambiguous molecular weight verification for 5-Amino-1MQ.
The monoisotopic mass of the 5-amino-1-methylquinolin-1-ium cation corresponds to m/z 159.09 [M]+ (or m/z 160.09 [M+H]+ depending on counterion ionization characteristics during ESI). The presence of a sharp, singular mass peak matching the target ionic formula confirms structural identity. Combining 5-amino-1mq hplc retention time data with ESI-MS spectral fingerprints eliminates false positives caused by isobaric synthesis artifacts.
A comprehensive Certificate of Analysis (COA) provides quantitative proof of chemical fidelity for every production lot. Laboratory investigators purchasing compounds for critical assays must verify that the COA contains complete, unedited raw data generated by an independent analytical facility.
Key elements of a valid 5-Amino-1MQ COA include:
1. Lot Identification: Specific lot and batch numbers matching the physical product vial.
2. HPLC Chromatogram: Full baseline graphical plot displaying primary peak retention, secondary peaks, and integration percentages.
3. Mass Spectrum: ESI-MS spectral output confirming target m/z ratio.
4. Quantitative Purity Determination: 5-amino-1mq purity expressed as a percentage of total integrated peak area (minimum threshold >98.0%).
5. Bioburden Analysis: Bacterial endotoxin levels measured via Chromogenic Reagent Limulus Amebocyte Lysate (LAL) testing, expressed in EU/mg.
PX1 Research establishes stringent benchmark criteria for all laboratory compounds to ensure maximum research integrity. Every batch of 5-Amino-1MQ undergoes rigorous testing in accredited facilities prior to distribution.
• Synthesis Origin: Fully manufactured in the United States within ISO-compliant production environments.
• Analytical Verification: Individual lot testing via high-resolution RP-HPLC and ESI-MS at independent ISO 17025 accredited laboratories.
• Purity Threshold: Verified 5-amino-1mq purity exceeding 98.0% by total area integration.
• Endotoxin Control: Comprehensive LAL testing ensuring endotoxin content remains strictly below 0.01 EU/mg.
• Documentation: Lot-specific COA available directly for download or inclusion with shipment.
• Logistics: Dispatch via same-day shipping (Monday through Friday) originating directly from optimized distribution hubs in California and Arizona.
When designing preclinical protocols to evaluate cellular metabolism, mitochondrial output, and energy expenditure, researchers frequently compare 5-Amino-1MQ against other established metabolic modulators. Each compound targets distinct biochemical pathways within cellular energy cascades.
While 5-Amino-1MQ acts specifically as an NNMT inhibitor to prevent NAD+ degradation, compounds like MOTS-c act as mitochondrial-derived peptides that regulate nuclear gene expression related to glucose homeostasis. Similarly, AICAR functions as an AMP-activated protein kinase (AMPK) agonist to directly stimulate fatty acid oxidation independent of NNMT activity. Meanwhile, small molecules such as SLU-PP-332 target estrogen-related receptors (ERRs) to promote oxidative muscle fiber phenotype transformation. Combining or contrasting these distinct tools allows investigators to map complex metabolic signaling networks in vitro.
Bacterial endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—pose a significant risk of experimental artifact in cell culture and animal models. Exposure to trace endotoxins can trigger toll-like receptor 4 (TLR4) inflammatory cascades in cultured macrophages, adipocytes, and hepatocytes, confounding measurements of metabolic flux and gene expression.
To protect research validity, PX1 Research subjects all 5-Amino-1MQ lots to quantitative LAL testing. Establishing an endotoxin threshold under 0.01 EU/mg ensures that observed cellular responses are attributable strictly to NNMT inhibition rather than immunogenic contaminants.
5-Amino-1MQ is supplied as a lyophilized or crystalline salt formulation requiring proper laboratory preparation prior to assay administration. Small molecule salt forms typically exhibit high solubility in polar organic solvents such as dimethyl sulfoxide (DMSO) and moderate solubility in aqueous buffers.
For in vitro stock preparation, dissolve the powder in molecular biology grade DMSO to achieve a stock concentration of 10 mM to 50 mM. Gentle vortexing and brief sonication in a warm water bath (25°C to 37°C) facilitate complete dissolution. Once fully dissolved in DMSO, stock solutions may be diluted into sterile cell culture media (e.g., DMEM or RPMI) ensuring that the final DMSO concentration does not exceed 0.1% v/v to avoid solvent-induced cytotoxicity.
Solid 5-Amino-1MQ powder exhibits excellent long-term stability when stored in a desiccated environment at -20°C, protected from light and atmospheric moisture. Vials should be allowed to equilibrate to room temperature prior to opening to prevent condensation inside the container.
Aqueous dilutions or DMSO stock solutions should be aliquoted into single-use polypropylene microcentrifuge tubes to prevent repeated freeze-thaw cycles. Reconstituted DMSO stock solutions remain stable at -80°C for up to 6 months. Liquid solutions stored at 4°C should be utilized within 48 to 72 hours to prevent gradual hydrolysis or oxidative degradation of the quinoline structure.
What is the standard 5-amino-1mq hplc purity threshold for research applications?
For reliable in vitro and preclinical research, the accepted threshold for 5-amino-1mq purity is ≥98.0% as measured by Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) peak integration.
How is 5-amino-1mq purity verified on a Certificate of Analysis?
Purity is verified by integrating the area under the main chromatogram peak produced by RP-HPLC and comparing it to total integrated peak areas. The COA provides both the graphical peak baseline and calculated percentage purity.
What mobile phase conditions are used for 5-amino-1mq hplc analysis?
Standard 5-amino-1mq hplc protocols utilize a gradient system of 0.1% trifluoroacetic acid (TFA) in LC-MS grade water (Mobile Phase A) and 0.1% TFA in LC-MS grade acetonitrile (Mobile Phase B) over a C18 silica column with UV detection at 254 nm.
Why is mass spectrometry performed alongside 5-amino-1mq hplc testing?
HPLC confirms chemical purity and separates impurities, while Electrospray Ionization Mass Spectrometry (ESI-MS) confirms exact molecular weight and structural identity, ensuring no isobaric contaminants are present.
What is the molecular weight and chemical structure of 5-Amino-1MQ?
5-Amino-1MQ (5-amino-1-methylquinolin-1-ium) is a small-molecule quinoline derivative with a cation molecular weight of approximately 159.09 g/mol (excluding associated salt counterion).
How should 5-Amino-1MQ be reconstituted for in vitro cell culture studies?
5-Amino-1MQ powder should be reconstituted in molecular biology grade DMSO to prepare concentrated stock solutions (e.g., 10–50 mM). Stocks can then be diluted into culture media to working concentrations while maintaining DMSO levels below 0.1% v/v.
What is the endotoxin limit for PX1 Research 5-Amino-1MQ lots?
PX1 Research mandates that every batch of 5-Amino-1MQ tests below 0.01 EU/mg via Chromogenic LAL testing to prevent endotoxin-induced immune artifacts in cellular assays.
How does NNMT inhibition by 5-Amino-1MQ impact intracellular NAD+ levels in rodent models?
In preclinical rodent models, inhibiting NNMT blocks the methylation of nicotinamide to 1-methylnicotinamide, thereby preserving nicotinamide for conversion back into NAD+ via the salvage pathway.
How does 5-Amino-1MQ compare to other mitochondrial research compounds like MOTS-c or AICAR?
5-Amino-1MQ functions specifically as a small-molecule enzyme inhibitor targeting NNMT to preserve NAD+. In contrast, MOTS-c is a mitochondrial peptide modulating nuclear transcription, and AICAR is a direct AMPK agonist.
What storage conditions prevent hydrolytic or oxidative degradation of 5-Amino-1MQ powder?
Lyophilized powder should be stored desiccated at -20°C, protected from light. Reconstituted DMSO stock aliquots must be stored at -80°C to avoid repeated freeze-thaw degradation.
Can PX1 Research provide bulk or wholesale quantities of 5-Amino-1MQ with custom analytical reports?
Yes. Institutional accounts and high-volume laboratories can request bulk packaging and comprehensive lot documentation through our [wholesale portal](/wholesale).
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.